More intriguingly, anlotinib triggered the S62 dephosphorylation and T58 phosphorylation of c-Myc, and promoted the ubiquitin proteasome-mediated degradation of c-Myc, which partially contributes to anlotinib-induced apoptosis in MM cells. Here, MYC is linked to Miyoshi myopathy.